The Pathophysiology and Treatment of Sepsis
The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Abstract
Sepsis is the leading cause of death in critically ill patients in the United States. Yet the individual host response to septicemia is variable, depending on the patient's immune response, age, nutritional status, and coexisting conditions, as well as on the virulence of the organism and the size of the inoculum. This review examines evolving concepts of sepsis and discusses new and potential therapies. Recent clinical advances include therapy with activated protein C, stringent control of blood glucose, and early goal-directed therapy to treat cellular oxygen deficit. Future therapies may be focused on modulating the immune response in the light of the characteristics of the specific pathogen, the genetic profile of the patient, and the duration of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Cited by
Items 101–200 of 215
Chung, S. W., Liu, X., Macias, A. A., Baron, R. M., & Perrella, M. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32730 · Cited by 325
Developing a Clinically Feasible Personalized Medicine Approach to Pediatric Septic Shock
Wong, H. R., Cvijanovich, N. Z., Anas, N., Allen, G. L., Thomas, N. J., Bigham, M. T., Weiss, S. L., Fitzgerald, J., Checchia, P. A., Meyer, K., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1864oc · Cited by 324
An extracorporeal blood-cleansing device for sepsis therapy
Kang, J. H., Super, M., Yung, C. W., Cooper, R. M., Domansky, K., Graveline, A. R., Mammoto, T., Berthet, J. B., Tobin, H., Cartwright, M. J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3640 · Cited by 321
Venet, F., Chung, C.-S., Kherouf, H., Geeraert, A., Malcus, C., Poitevin, F., Bohé, J., Lepape, A., Ayala, A., & Monneret, G. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1337-8 · Cited by 320
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans
Ferwerda, B., McCall, M. B. B., Alonso, S., Giamarellos-Bourboulis, E. J., Mouktaroudi, M., Izagirre, N., Syafruddin, D., Kibiki, G., Cristea, T., Hijmans, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704828104 · Cited by 318
The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?
Boomer, J. S., Green, J. M., & Hotchkiss, R. S. (2014) · Virulence · doi:10.4161/viru.26516 · Cited by 317
Self-citationThe alternative complement pathway revisited
Harboe, M., & Mollnes, T. E. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00350.x · Cited by 316
Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study
Ishani, A., Collins, A. J., Herzog, C. A., & Foley, R. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00414.x · Cited by 313
Sepsis-Associated Acute Kidney Injury
Manrique-Caballero, C. L., Del Rio-Pertuz, G., & Gomez, H. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2020.11.010 · Cited by 312
IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
Unsinger, J., McGlynn, M., Kasten, K. R., Hoekzema, A. S., Watanabe, E., Muenzer, J. T., McDonough, J. S., Tschoep, J., Ferguson, T. A., McDunn, J. E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903151 · Cited by 312
Self-citationPathogenesis of filoviral haemorrhagic fevers
Mahanty, S., & Bray, M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01103-x · Cited by 310
Current trends in inflammatory and immunomodulatory mediators in sepsis
Aziz, M., Jacob, A., Yang, W.-L., Matsuda, A., & Wang, P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912437 · Cited by 309
Prognostic utility and characterization of cell-free DNA in patients with severe sepsis
Dwivedi, D. J., Toltl, L. J., Swystun, L. L., Pogue, J., Liaw, K.-L., Weitz, J. I., Cook, D. J., Fox-Robichaud, A. E., Liaw, P. C., & the Canadian Critical Care Translational Biology Group (2012) · Critical Care · doi:10.1186/cc11466 · Cited by 306
Brahmamdam, P., Inoue, S., Unsinger, J., Chang, K. C., McDunn, J. E., & Hotchkiss, R. S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0110037 · Cited by 305
Self-citationChang, K., Svabek, C., Vazquez-Guillamet, C., Sato, B., Rasche, D., Wilson, S., Robbins, P., Ulbrandt, N., Suzich, J., Green, J., et al. (2014) · Critical Care · doi:10.1186/cc13176 · Cited by 304
Self-citationIdentification of pediatric septic shock subclasses based on genome-wide expression profiling
Wong, H. R., Cvijanovich, N., Lin, R., Allen, G. L., Thomas, N. J., Willson, D. F., Freishtat, R. J., Anas, N., Meyer, K., Checchia, P. A., et al. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-34 · Cited by 303
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
Luk, T., Malam, Z., & Marshall, J. C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807581 · Cited by 302
Horiuchi, K., Kimura, T., Miyamoto, T., Takaishi, H., Okada, Y., Toyama, Y., & Blobel, C. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2686 · Cited by 301
Sepsis: Inflammation Is a Necessary Evil
Nedeva, C., Menassa, J., & Puthalakath, H. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00108 · Cited by 301
Red cell distribution width and all-cause mortality in critically ill patients*
Bazick, H. S., Chang, D., Mahadevappa, K., Gibbons, F. K., & Christopher, K. B. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821b85c6 · Cited by 300
Landelle, C., Lepape, A., Voirin, N., Tognet, E., Venet, F., Bohé, J., Vanhems, P., & Monneret, G. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1962-x · Cited by 296
Hou, X., Zhang, X., Zhao, W., Zeng, C., Deng, B., McComb, D. W., Du, S., Zhang, C., Li, W., & Dong, Y. (2020) · Nature Nanotechnology · doi:10.1038/s41565-019-0600-1 · Cited by 290
Yang, J., Zhang, R., Zhao, H., Qi, H., Li, J., Li, J., Zhou, X., Wang, A., Fan, K., Yan, X., et al. (2022) · Exploration · doi:10.1002/exp.20210267 · Cited by 289
IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality
Zhang, H., Neuhöfer, P., Song, L., Rabe, B., Lesina, M., Kurkowski, M. U., Treiber, M., Wartmann, T., Regnér, S., Thorlacius, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64931 · Cited by 288
Statin treatment after onset of sepsis in a murine model improves survival.
Merx, M. W., Liehn, E. A., Graf, J., van de Sandt, A., Schaltenbrand, M., Schrader, J., Hanrath, P., & Weber, C. (2005) · Circulation · doi:10.1161/circulationaha.104.502195 · Cited by 287
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Eloseily, E. M., Weiser, P., Crayne, C. B., Haines, H., Mannion, M. L., Stoll, M. L., Beukelman, T., Atkinson, T. P., & Cron, R. Q. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41103 · Cited by 282
“165 Clinical presentation Persistent fever 43 (98) 31 (97) 12 (100) 1 Hepatomegaly 13 (30) 10 (31) 3 (25) 1 Splenomegaly 15 (34) 12 (38) 3 (25) 0.”
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study
Christ-Crain, M., Morgenthaler, N. G., Struck, J., Harbarth, S., Bergmann, A., & Müller, B. (2005) · Critical Care · doi:10.1186/cc3885 · Cited by 281
Hüttemann, M., Helling, S., Sanderson, T. H., Sinkler, C., Samavati, L., Mahapatra, G., Varughese, A., Lu, G., Liu, J., Ramzan, R., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.001 · Cited by 278
HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis
Merx, M. W., Liehn, E. A., Janssens, U., Lütticken, R., Schrader, J., Hanrath, P., & Weber, C. (2004) · Circulation · doi:10.1161/01.cir.0000129774.09737.5b · Cited by 277
Animal models of sepsis: Why does preclinical efficacy fail to translate to the clinical setting?
Dyson, A., & Singer, M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181922bd3 · Cited by 273
Schefold, J. C., Bierbrauer, J., & Weber-Carstens, S. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0010-6 · Cited by 268
Bray, M., & Geisbert, T. W. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.02.018 · Cited by 265
Such stuff as dreams are made on: mediator-directed therapy in sepsis
Marshall, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1084 · Cited by 264
NAD+-dependent SIRT1 Deacetylase Participates in Epigenetic Reprogramming during Endotoxin Tolerance
Liu, T. F., Yoza, B. K., El Gazzar, M., Vachharajani, V. T., & McCall, C. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.196790 · Cited by 264
Schildberger, A., Rossmanith, E., Eichhorn, T., Strassl, K., & Weber, V. (2013) · Mediators of Inflammation · doi:10.1155/2013/697972 · Cited by 262
Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice
Miyaji, T., Hu, X., Yuen, P. S. T., Muramatsu, Y., Iyer, S., Hewitt, S. M., & Star, R. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00268.x · Cited by 261
Synthetic Ligand-Coated Magnetic Nanoparticles for Microfluidic Bacterial Separation from Blood
Lee, J.-J., Jeong, K. J., Hashimoto, M., Kwon, A. H., Rwei, A., Shankarappa, S. A., Tsui, J. H., & Kohane, D. S. (2014) · Nano Letters · doi:10.1021/nl3047305 · Cited by 258
Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy
Prauchner, C. A. (2017) · Burns · doi:10.1016/j.burns.2016.09.023 · Cited by 256
Endotoxins and Other Sepsis Triggers
Opal, S. M. (2010) · Contributions to Nephrology · doi:10.1159/000315915 · Cited by 256
Wong, H. R., Cvijanovich, N., Allen, G. L., Lin, R., Anas, N., Meyer, K., Freishtat, R. J., Monaco, M., Odoms, K., Sakthivel, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819fcc08 · Cited by 255
Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis
Wurfel, M. M., Gordon, A. C., Holden, T. D., Radella, F., Strout, J., Kajikawa, O., Ruzinski, J. T., Rona, G., Black, A. R., Stratton, S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-462oc · Cited by 244
“Secondary outcome variables included (1) the days alive and free of organ dysfunction (cardiovascular, respiratory, hepatic, coagulation, and neurologic) as defined by the Brussels criteria (15), (2) days alive and free of vasopressor use or mechanical ventilation, and (3) the prevalence of positive bacterial cultures.”
BackgroundTLRs Govern Neutrophil Activity in Aspergillosis
Bellocchio, S., Moretti, S., Perruccio, K., Fallarino, F., Bozza, S., Montagnoli, C., Mosci, P., Lipford, G. B., Pitzurra, L., & Romani, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7406 · Cited by 242
“These results reinforce the concept that TLR dysfunction may play a role in the proinflammatory response and pathophysiology of polymicrobial sepsis (17, 56).”
BackgroundROLE OF TOLL-LIKE RECEPTORS IN THE DEVELOPMENT OF SEPSIS
Tsujimoto, H., Ono, S., Efron, P. A., Scumpia, P. O., Moldawer, L. L., & Mochizuki, H. (2008) · Shock · doi:10.1097/shk.0b013e318157ee55 · Cited by 239
“This supports the proposal that other components, including other bacterial molecular elements, may contribute to the development of sepsis (8).”
BackgroundUCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238
RetractedRitter, C., Andrades, M. E., Reinke, A., Menna-Barreto, S., Moreira, J. C. F., & Dal-Pizzol, F. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000109454.13145.ca · Cited by 233
Johnson, G. B., Brunn, G. J., & Platt, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.20 · Cited by 232
“Although some conditions in which SIRS is seen, such as multiorgan traumas, might lead to infection and thus to sepsis, efforts to identify infecting organisms in many patients with SIRS fail (3, 4).”
BackgroundInfections of the Urinary Tract
(1936) · Journal of the American Medical Association · doi:10.1001/jama.1936.02770030073043 · Cited by 232
Sun, Y., Li, Q., Gui, H., Xu, D.-P., Yang, Y.-L., Su, D.-F., & Liu, X. (2013) · Cell Research · doi:10.1038/cr.2013.116 · Cited by 230
Beurel, E., & Jope, R. S. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-9 · Cited by 228
“Sepsis ensues due to hyperactivation of the innate immune system that causes a massive production of proinflammatory cytokines and chemokines that cause vascular leakage and septic shock, impairing the function of vital organs [1].”
BackgroundTrzeciak, S., Cinel, I., Phillip Dellinger, R., Shapiro, N. I., Arnold, R. C., Parrillo, J. E., Hollenberg, S. M., & on behalf of the Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators (2008) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2008.00109.x · Cited by 225
“S epsis is a common and devastating disease that is responsible for 215,000 deaths annually in the United States and is the leading cause of death in critically ill patients.(1,2) This disease is now recognized to be a time-sensitive emergency, because patients stand the best chance for survival when effective therape…”
BackgroundWang, X., Zhang, G., Jiang, X., Zhu, H., Lu, Z., & Xu, L. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.003 · Cited by 225
The Pathophysiology of Sepsis-Associated AKI
Kuwabara, S., Goggins, E., & Okusa, M. D. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00850122 · Cited by 224
Lactate and Immunosuppression in Sepsis
Nolt, B., Tu, F., Wang, X., Ha, T., Winter, R., Williams, D. L., & Li, C. (2018) · Shock · doi:10.1097/shk.0000000000000958 · Cited by 219
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
Pacher, P., & Haskó, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707582 · Cited by 217
Zhao, L., An, R., Yang, Y., Yang, X., Liu, H., Yue, L., Li, X., Lin, Y., Reiter, R. J., & Qu, Y. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12254 · Cited by 217
“Sepsis is a severe systemic inflammatory response to infection, which is the leading cause of death in the critically ill and causes high morbidity and mortality among the patients [1, 2].”
BackgroundXie, K., Yu, Y., Pei, Y., Hou, L., Chen, S., Xiong, L., & Wang, G. (2010) · Shock · doi:10.1097/shk.0b013e3181cdc4ae · Cited by 213
“and death associated with sepsis are not fully understood (3), it has been exceedingly difficult to develop measures that reduce the high mortality rate.”
BackgroundAbe, R., Oda, S., Sadahiro, T., Nakamura, M., Hirayama, Y., Tateishi, Y., Shinozaki, K., & Hirasawa, H. (2010) · Critical Care · doi:10.1186/cc8898 · Cited by 211
“Despite recent advances in critical care medicine, the mortality of sepsis in ICU remains high [1,2].”
BackgroundMarechal, X., Favory, R., Joulin, O., Montaigne, D., Hassoun, S., Decoster, B., Zerimech, F., & Neviere, R. (2008) · Shock · doi:10.1097/shk.0b013e318157e926 · Cited by 210
Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality
Choi, H., Kim, Y., Mirzaaghasi, A., Heo, J., Kim, Y. N., Shin, J. H., Kim, S., Kim, N. H., Cho, E. S., In Yook, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz6980 · Cited by 203
Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality*
Braun, A. B., Gibbons, F. K., Litonjua, A. A., Giovannucci, E., & Christopher, K. B. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822d74f3 · Cited by 201
Chen, X., El Gazzar, M., Yoza, B. K., & McCall, C. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000950 · Cited by 201
Toward Resolving the Challenges of Sepsis Diagnosis
Carrigan, S. D., Scott, G., & Tabrizian, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032144 · Cited by 200
“... efficacy of which is currently undergoing clinical evaluation, involves lowdose administration of the corticosteroid methylprednisolone, which suppresses inflammation by decreasing the concentrations of TNF and IL-6 and decreasing NF-B activity in leukocytes (114 ). In contrast to these antiinflammatory therapies,…”
BackgroundResultIL-7 Restores Lymphocyte Functions in Septic Patients
Venet, F., Foray, A.-P., Villars-Méchin, A., Malcus, C., Poitevin-Later, F., Lepape, A., & Monneret, G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202062 · Cited by 199
“Discussion Severe sepsis and septic shock represent the first cause of mortality in ICU (17).”
BackgroundInfluentialEndotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs
Lu, J.-Y., Sadri, N., & Schneider, R. J. (2006) · Genes & Development · doi:10.1101/gad.1467606 · Cited by 198
Evidence of myocardial hibernation in the septic heart*
Levy, R. J., Piel, D. A., Acton, P. D., Zhou, R., Ferrari, V. A., Karp, J. S., & Deutschman, C. S. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000189943.60945.77 · Cited by 196
Hoetzenecker, W., Echtenacher, B., Guenova, E., Hoetzenecker, K., Woelbing, F., Brück, J., Teske, A., Valtcheva, N., Fuchs, K., Kneilling, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2557 · Cited by 196
“Some affected individuals die from secondary infections during the phase of SAI”
BackgroundBlood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients?
Dewitte, A., Lepreux, S., Villeneuve, J., Rigothier, C., Combe, C., Ouattara, A., & Ripoche, J. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0337-7 · Cited by 194
Mechanisms of Mortality in Early and Late Sepsis
Xiao, H., Siddiqui, J., & Remick, D. G. (2006) · Infection and Immunity · doi:10.1128/iai.01220-05 · Cited by 194
“The data in this paper provide evidence that the proposed progression from SIRS to CARS is probably not linear but rather constantly changing and that it requires close observation.”
BackgroundInfluentialPlatelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review
Kurtul, A., & Ornek, E. (2019) · Angiology · doi:10.1177/0003319719845186 · Cited by 192
Acute Lung Injury:Apoptosis and Signaling Mechanisms
Chopra, M., Reuben, J. S., & Sharma, A. C. (2009) · Experimental Biology and Medicine · doi:10.3181/0811-mr-318 · Cited by 191
“According to this ‘‘neutrophil hypothesis,’’ the switch from a proinflammatory to an anti-inflammatory environment is postponed (10, 35).”
BackgroundRole of protease-activated receptors in inflammatory responses, innate and adaptive immunity
Shpacovitch, V, Feld, M., Hollenberg, M. D., Luger, T. A., & Steinhoff, M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108001 · Cited by 190
“Moreover, the circulating LPS levels in septic human patients are also reported to be low [113, 114].”
BackgroundLong-term Cognitive and Functional Impairments After Critical Illness
Rengel, K. F., Hayhurst, C. J., Pandharipande, P. P., & Hughes, C. G. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004066 · Cited by 189
Antithrombin: anti-inflammatory properties and clinical applications
Sniecinski, R. M., Welsby, I. J., Levi, M., & Levy, J. H. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-08-0687 · Cited by 188
“Sepsis – the leading cause of death in critically ill patients in the United States – is characterised by an uncontrolled systemic inflammatory response (89).”
BackgroundProtection from lethal septic peritonitis by neutralizing the biological function of interleukin 27
Wirtz, S., Tubbe, I., Galle, P. R., Schild, H. J., Birkenbach, M., Blumberg, R. S., & Neurath, M. F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060471 · Cited by 186
“However, excessive infl ammation in bacterial infections can lead to marked tissue damage and lethal septic shock (1, 2).”
Role of Innate Host Defenses in Susceptibility to Early-Onset Neonatal Sepsis
Wynn, J. L., & Levy, O. (2010) · Clinics in Perinatology · doi:10.1016/j.clp.2010.04.001 · Cited by 185
Spinal and supraspinal effects of activity in ligament afferents
Sjölander, P., Johansson, H., & Djupsjöbacka, M. (2002) · Journal of Electromyography and Kinesiology · doi:10.1016/s1050-6411(02)00017-2 · Cited by 185
Mitochondrial Function in Sepsis
Arulkumaran, N., Deutschman, C. S., Pinsky, M. R., Zuckerbraun, B., Schumacker, P. T., Gomez, H., Gomez, A., Murray, P., & Kellum, J. A. (2016) · Shock · doi:10.1097/shk.0000000000000463 · Cited by 184
“’’ Cellular hibernation in renal epithelial cells would be consistent with the low levels of cell death observed in septic patients with AKI (106).”
Haemophagocytic syndromes in adults: current concepts and challenges ahead
Emmenegger, U., Schaer, D., Larroche, C., & Neftel, K. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.10976 · Cited by 184
How do viral infections predispose patients to bacterial infections?
Beadling, C., & Slifka, M. K. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200406000-00003 · Cited by 183
Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis
Danielski, L. G., Giustina, A. D., Badawy, M., Barichello, T., Quevedo, J., Dal-Pizzol, F., & Petronilho, F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-016-0356-7 · Cited by 182
Proietti, M., Cornacchione, V., Rezzonico Jost, T., Romagnani, A., Faliti, C. E., Perruzza, L., Rigoni, R., Radaelli, E., Caprioli, F., Preziuso, S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.010 · Cited by 181
Antonioli, L., Colucci, R., La Motta, C., Tuccori, M., Awwad, O., Da Settimo, F., Blandizzi, C., & Fornai, M. (2012) · Current Drug Targets · doi:10.2174/138945012800564095 · Cited by 179
Regulation of Endothelial Barrier Function
Yuan, S. Y., & Rigor, R. R. (2011) · Colloquium Series on Integrated Systems Physiology: From Molecule to Function · doi:10.4199/c00025ed1v01y201101isp013 · Cited by 177
Recommendations for sepsis management in resource-limited settings
Dünser, M. W., Festic, E., Dondorp, A., Kissoon, N., Ganbat, T., Kwizera, A., Haniffa, R., Baker, T., Schultz, M. J., & Global Intensive Care Working Group of the European Society of Intensive Care Medicine (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2468-5 · Cited by 176
“Background Apart from tissue hypoperfusion, organ dysfunction associated with sepsis arises from hypoxemia [46], which is highly prevalent in resource-limited settings [47].”
BackgroundEnergy crisis: The role of oxidative phosphorylation in acute inflammation and sepsis
Lee, I., & Hüttemann, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.031 · Cited by 169
“Thismay contribute to a failure of the immune system since the prevention of lymphocyte apoptosiswas shown to improve survival [59].”
BackgroundThe systemic inflammatory response syndrome
Robertson, C. M., & Coopersmith, C. M. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.12.016 · Cited by 169
Sepsis Induces Early Alterations in Innate Immunity That Impact Mortality to Secondary Infection
Delano, M. J., Thayer, T., Gabrilovich, S., Kelly-Scumpia, K. M., Winfield, R. D., Scumpia, P. O., Cuenca, A. G., Warner, E., Wallet, S. M., Wallet, M. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002104 · Cited by 165
Alcayaga-Miranda, F., Cuenca, J., Martin, A., Contreras, L., Figueroa, F. E., & Khoury, M. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0192-0 · Cited by 165
“With the progression of sepsis, the adaptive immune system reduces their efficiency by an increase in antiinflammatory mediators and loss of T and B cells via apoptosis [30, 31].”
Huang, J., Zhang, Q., Wang, R., Ji, H., Chen, Y., Quan, X., & Zhang, C. (2019) · Medical Science Monitor · doi:10.12659/msm.919802 · Cited by 164
Validation of a gene expression-based subclassification strategy for pediatric septic shock*
Wong, H. R., Cvijanovich, N. Z., Allen, G. L., Thomas, N. J., Freishtat, R. J., Anas, N., Meyer, K., Checchia, P. A., Lin, R., Shanley, T. P., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182257675 · Cited by 164
Venet, F., Pachot, A., Debard, A.-L., Bohe, J., Bienvenu, J., Lepape, A., Powell, W. S., & Monneret, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6540 · Cited by 158
Pediatric Post-Discharge Mortality in Resource Poor Countries: A Systematic Review
Wiens, M. O., Pawluk, S., Kissoon, N., Kumbakumba, E., Ansermino, J. M., Singer, J., Ndamira, A., & Larson, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066698 · Cited by 144
“Sepsis, the most common cause of death among children in developing countries [19,20], is known to cause significant losses in adaptive immunity [21], perhaps contributing to the significant burden of post-discharge mortality observed.”
BackgroundRodriguez, S., Chora, A., Goumnerov, B., Mumaw, C., Goebel, W. S., Fernandez, L., Baydoun, H., HogenEsch, H., Dombkowski, D. M., Karlewicz, C. A., et al. (2009) · Blood · doi:10.1182/blood-2009-04-214916 · Cited by 135
Núñez, V., Alameda, D., Rico, D., Mota, R., Gonzalo, P., Cedenilla, M., Fischer, T., Boscá, L., Glass, C. K., Arroyo, A. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913545107 · Cited by 133
“Sepsis is a very complex syndrome in which the underlying inflammatory response involves the interplay of several biological systems (the complement, coagulation, and fibrinolytic cascades and the autonomic nervous system) and cell types, resulting in an imbalance of the inflammatory network (17, 38).”
BackgroundHuggins, M. A., Sjaastad, F. V., Pierson, M., Kucaba, T. A., Swanson, W., Staley, C., Weingarden, A. R., Jensen, I. J., Danahy, D. B., Badovinac, V. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.028 · Cited by 114
Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation
Haberecht-Müller, S., Krüger, E., & Fielitz, J. (2021) · Biomolecules · doi:10.3390/biom11091327 · Cited by 108
Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages
Liang, X., Lin, T., Sun, G., Beasley-Topliffe, L., Cavaillon, J.-M., & Warren, H. S. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1208742 · Cited by 106
“There has been intense interest in the pro- and anti- inflammatory balance of patients with severe Gram-negative bacterial infection because inappropriate, uncontrolled systemic inflammation is believed to be important in the pathophysiology of sepsis [6, 7, 27].”
BackgroundDeletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy
Huang, N., Kny, M., Riediger, F., Busch, K., Schmidt, S., Luft, F. C., Slevogt, H., & Fielitz, J. (2017) · Intensive Care Medicine Experimental · doi:10.1186/s40635-016-0115-0 · Cited by 95
“Cytoplasmic receptors of the nucleotide binding domain (NOD)-like receptor (NLR) family are key components of the inflammasome, of which the best characterized NLR is NLRP3 [31, 32].”
BackgroundInfluentialBlood culture-free ultra-rapid antimicrobial susceptibility testing
Kim, T. H., Kang, J., Jang, H., Joo, H., Lee, G. Y., Kim, H., Cho, U., Bang, H., Jang, J., Han, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07725-1 · Cited by 90
Reduction in Mortality Associated with Statin Therapy in Patients with Severe Sepsis
Dobesh, P. P., Klepser, D. G., McGuire, T. R., Morgan, C. W., & Olsen, K. M. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.621 · Cited by 88
Metadata
- Authors
- Hotchkiss, R. S., & Karl, I. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-01-09
- Volume
- 348
- Issue
- 2
- Pages
- 138-150
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1977905350
- Cited by
- 4,097
- References
- 107
- FWCI
- 127.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.